Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Kadmon Pharmaceuticals announced the availability of Ribasphere Ribapak (ribavirin tablets) 600mg for the treatment of adults with chronic Hepatitis C infection in combination with peginterferon alfa-2a who have compensated liver disease and have not been previously treated with interferon alpha.
Ribasphere Ribapak is a daily 2-pill treatment taken in the morning and evening. Finishing a RibaPak reminds patients to administer their peginterferon injection. Ribavirin is a nucleoside analogue with activity against Hepatitis C virus genotypes 1–4.
Each Ribasphere RibaPak contains a 7-day supply (14 tablets). Ribasphere RibaPak is already available in 800mg, 1,000mg, and 1,200mg dosage strengths supplied in four-sleeve cartons.
For more information call (724) 778-6100 or visit www.ribapak.com.
